<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epidermal growth factor (EGF) is implicated in the regeneration of epithelial cells at the site of <z:mp ids='MP_0001845'>inflammation</z:mp> or ulceration in the gastrointestinal tract </plain></SENT>
<SENT sid="1" pm="."><plain>Single parotid EGF concentration and production was studied in 64 patients with Barrett's <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar lined oesophagus</z:e> (CLO), in 22 patients with severe <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> without columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> and in 51 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="2" pm="."><plain>In control patients, mean salivary EGF concentration was 2790 pg/ml (median 1450 pg/ml; range 450-16,500 pg/ml) and mean single parotid EGF production was 2550 pg/min (median 1750 pg/min; range 790-18,000 pg/min) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with severe <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> had a similar EGF concentration (mean 3112 pg/ml; median 1500 pg/ml; range 300-16,000 pg/ml) and production (mean 3100 pg/min; median 2200 pg/min; range 790-17,950 pg/min) to controls </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with CLO had a 62 per cent lower mean EGF concentration (mean 1197 pg/ml; median 640 pg/ml; range 233-4500 pg/ml) (P less than 0.001, Mann-Whitney U test) and a 60 per cent lower EGF production (mean 1254 pg/min; median 800 pg/min; range 170-3125 pg/min) (P less than 0.001, Mann-Whitney U test) than patients with severe <z:e sem="disease" ids="C0677659,C0014869" disease_type="Disease or Syndrome" abbrv="">reflux oesophagitis</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>A subpopulation with malignant change in CLO (n = 16) had a similar EGF concentration and production to the CLO group as a whole (mean 1240 and 1300 pg/min, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>Low salivary EGF levels are associated with Barrett's CLO but not with severe <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> without columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>EGF levels do not identify those patients who will subsequently develop malignant change </plain></SENT>
</text></document>